[Tumor necrosis factor modulators in the treatment of rheumatoid arthritis].
Konttinen
Y T
YT
yrjo.konttinen@helsinki.fi
Valleala
H
H
Honkanen
V
V
Törnwall
J
J
Tensing
E K
EK
Sorsa
T
T
Nordström
D
D
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha
Tuumorinekroositekijämodulaattorit nivelreuman hoidossa.